Item Details

13 Nov 2026

Oman Launches OMR 6.5 Million Radiopharmaceutical Facility

On 8 November, Oman Investment Authority launched the Oman Nucleus project with an estimated investment of OMR 6.5 million to produce radiopharmaceuticals for diagnosis and treatment. The project creates opportunities in medical equipment, laboratory systems and pharmaceutical supply chains. HPC can help identify qualified healthcare suppliers and technical partners.

Get in Touch

We’ll get back to you shortly.